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the progression of renal dysfunction even after adjusting for
other clinical risk factors, including hypertension, urinary pro-
tein excretion of more than 1.0 g/day, and no administration
of renin angiotensin system inhibitors. This study supports the
role of MUC20 in regulating the Met signaling cascade, which is
implicated not only in renal development and maintenance of
kidney functions but also in tubular repair and regeneration un-
der pathological conditions in human glomerulonephritis. The
tandem repeat polymorphism in MUC20, which may directly
affect its oligomerization and binding to Met, is associated with
the renal prognosis of IgAN. Factors that regulate the function
of MUC20 may be useful therapeutic agents for progression of
renal injury.
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The use of animal organs for human transplantation could
potentially alleviate the worldwide critical shortage of donor
organs, and thus has stimulated investigation of novel strate-
gies directed at making xenotransplantation applicable to the
clinic. The latter will likely require overcoming barriers of rejec-
tion through strategies utilizing either immune suppression or
tolerance induction, or a combination of the two. We have pre-
viously reported that vascularized donor thymic tissue grafts,
transplanted either as composite thymokidneys or vascularized
thymic lobe grafts, induced tolerance across fully allogeneic bar-
riers in miniature swine. Recently, we have applied the strat-
egy of vascularized thymic lobe transplantation in a model of
hDAF pig-to-baboon xenotransplantation and demonstrated
that these grafts induced donor-specific unresponsiveness for
up to 2 to 3 months following transplantation, at which time the
grafts were lost from apparent humoral rejection. We have now
extended these studies using cloned a-1,3-galactosyltransferase
(GalT) knockout pigs as donors. We report here our initial ex-
perience in a preclinical model of pig-to-baboon xenotrans-
plantation. This abstract presents clinical data on recipients
of GalT knockout kidneys, especially focusing on four long-
term recipients of GalT knockout kidney plus thymus trans-
plantation in detail. Briefly, these four baboons receiving either
xeno-thymokidneys or vascularized thymic lobe plus kidney
maintained longer than 2 months. Three of four long-term sur-
vivors maintained normal plasma creatinine levels for 56, 68,
and 83 days, respectively, before expiring from unexpected
causes (anesthetic complication during surgery to replace an
infected intravenous catheter (day 68), and myocardial infarc-
tion, possibly drug-induced on days 56 and an arterial catheter
trouble on day 83. Cytotoxic T-lymphocyte assays on day 78
in one long-term acceptor showed that the baboon maintained
anti-allo cytotoxic T-lymphocyte responses but lost antipig cyc-
totoxic T-lymphocyte responses, indicating donor-specific un-
responsiveness. The fourth baboon experienced an apparent
rejection crisis between days 53 and 65, which reversed with
anti-T-cell rejection therapy; subsequently the animal expired
on day 81 from pneumonia. Neither hyperacute nor acceler-
ated acute rejection was observed in any animal. Use of GalT
knockout donors markedly extends the survival of vascularized
thymus plus renal xenografts in baboons. Although the induc-
tion regimen still needs to be modified to reduce complications,
these initial results are encouraging with regard to the poten-
tial of cotransplanting vascularized thymic tissue with organ
xenografts as a means of achieving long-term tolerance across
pig-to-primate barriers.
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The introduction of cyclosporine (CsA) into clinical practice
has resulted in marked improvement in the short-term outcome
of organ transplantation, and 1-year survival of renal allografts
has improved significantly. However, the annual rate of kidney
graft loss caused by chronic allograft nephropathy (CAN) has
remained stable over last decade. CAN may result from peri-
operative ischemia at the time of transplantation. Furthermore,
chronic CsA nephrotoxicity may progress to an irreversible re-
nal lesion characterized by tubular atrophy, striped interstitial
fibrosis, hyalinosis of the afferent arteriole, and progressive re-
nal impairment. Recent report demonstrated the therapeutic
effects of hepatocyte growth factor (HGF) in preventing CAN
using a well-established rat CAN model. They showed that
HGF treatment during the initial 4 weeks after engraftment
